AdipoGen Life Sciences rare biologically active antibiotics and mycotoxins

AdipoGen Life Sciences offers a broad panel of >500 natural products from bacterial, fungal, marine and plant sources. Included in this panel are key standard research antibiotics; rare metabolites/antibiotics with new chemical structures; old, already forgotten substances with new modes of action; and new molecular targets.

These products include rifamycins, lantibiotics, thiazolyl peptides, antibiotics for cancer research, antibiotics for inflammation and neuroscience research, mycotoxins, synthetic antibiotics and more. These substances can be used for in vitro or in vivo studies based on their biological activities or as standard secondary metabolites, important as chemo-taxonomic markers of microbial species.

The company also has a range of lantibiotics, which are a subset of lanthipeptides with antimicrobial activity. Lantibiotics provide significant leads in the ongoing fight against the rise of antibiotic-resistant strains of bacteria and are active against multidrug-resistant Gram-positive pathogens.